The ATV groups at variable doses (10, 20 and 40 mg/(kg·day)) demonstrated elevated levels of ALT and AST with reduced levels of BUN and Cr, as the differences were not significant, the effects on liver and kidney function were minor (P>0.05) compared with the diabetes group. Here, GPT is linked to diabetes mellitus.